Filing Details

Accession Number:
0001415889-22-002663
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-03-07 17:00:22
Reporting Period:
2022-03-03
Accepted Time:
2022-03-07 17:00:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1326732 Xencor Inc XNCR Pharmaceutical Preparations (2834) 201622502
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591312 I Bassil Dahiyat C/O Xencor, Inc.
111 W. Lemon Ave
Monrovia CA 91016
President & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2022-03-03 2,929 $29.90 160,548 No 4 S Direct
Common Stock Acquisiton 2022-03-03 49,761 $0.00 210,309 No 4 A Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 A Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Acquisiton 2022-03-03 298,567 $0.00 298,567 $30.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
298,567 2032-03-02 No 4 A Direct
Footnotes
  1. Represents the disposition of shares that were sold to pay withholding taxes upon vesting of 7,868 restricted stock units.
  2. The weighted average sale price for the transaction reported was $29.9013, and the range of prices were between $29.86 and $29.93. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
  3. Includes the following shares acquired by the reporting person pursuant to the Issuer's Employee Stock Purchase Plan: 196 shares acquired in June 2021 and 218 shares acquired in December 2021.
  4. Represents restricted stock units that vest as follows: 1/3 of the shares vest on the first, second and third anniversaries of the date of grant.
  5. 25% of the shares subject to the option shall vest on the one year anniversary of March 3, 2022 (the "Vesting Commencement Date") and 1/48th of the shares shall vest monthly thereafter, such that the option shall be fully vested on the four year anniversary of the Vesting Commencement Date.